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ABSTRACT
Sezary syndrome, a rare disease, is the leukemic counterpart of mycosis fungoides accounting for less than 5% of cutaneous lymphomas. 
Very few case reports have been published of Sezary syndrome/mycosis fungoides presenting in young male and with coexisting HIV. 
We present a case of a 23-year-old retropositive male presenting with Sezary syndrome which is very rare. The present case highlights 
the fact that Sezary syndrome can rarely present in young and retropositive patients. It should be kept in differential diagnosis if a 
patient presents with erythroderma, generalized lymphadenopathy and characteristic peripheral smear findings. A multimodal approach 
involving flow cytometry, skin biopsy and fine needle aspiration cytology (FNAC) is required for arriving at a definite diagnosis.
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Sezary syndrome includes three signs: erythroderma, generalized lymphadenopathy, and presence of Sezary cells in the skin, lymph nodes and peripheral blood. 
One of the following is also needed for making a diagnosis: 
an absolute Sezary cell count >1000/microlitre, CD4: CD8 
ratio of >10 and loss of one or more T cell antigens [1]. 
Cutaneous lymphomas are as such rare, amongst which 
Sezary syndrome has a very low incidence constituting less 
than 5% of them. It presents in elderly patients with a median 
age of 60 years with a male preponderance [1]. Very few case 
reports of Sezary syndrome/mycosis fungoides presenting in 
young male and with coexisting HIV have been published 
[2-5]. It is one of the rare HIV associated neoplasms. We 
present a young retropositive male who was diagnosed with 
Sezary syndrome.
CASE REPORT
A 22-year-old retro-positive male was presented with complaints 
of multiple erythematous papular lesions, first appearing on 
the trunk and spreading to both upper and lower limbs over a 
span of seven days. The patient did not have fever, vomiting, 
photosensitivity or any drug intake.
On examination, numerous elevated reddish papular lesions 
measuring 5mm were present all over on the trunk, upper and 
lower extremities. There was widespread scaling which was 
found in the various sites of the body (Fig. 1) and the patient also 
had significant lymph nodes (submental, bilateral submandibular, 
jugular, axillary, inguinal). With the above findings in a 
retropositive male, a provisional diagnosis of immune response 
inflammatory syndrome was made. 
A routine CBC was done which helped to arrive at the diagnosis. 
The peripheral smear showed raised WBC count of 30,000/mm3 
with increased lymphocytes (80%), an absolute lymphocyte count 
of 24,000/ mm3. Also, 34% of these lymphoid cells (8160/ mm3) 
were found to have characteristic cerebriform nuclei (Fig. 2). To 
confirm the diagnosis, flow cytometry of peripheral blood was 
performed which revealed a moderately bright lymphoid cluster 
on CD45/SSC analysis comprising of 56% of the total acquired 
events. Total 98% of these cells were found to be of T lymphoid 
type on CD19/SSC analysis. These cells showed heterogenous 
positivity for CD5, CD3 (dim to moderate) and were found to be 
negative for CD7. Also, 97% of these cells were positive for CD4, 
indicating a significantly raised CD4: CD8 ratio (Fig. 3). 
Hence, based on these immunophenotypic findings a 
diagnosis of T cell lymphoproliferative disorder, possibly Sezary 
syndrome, was rendered and both skin biopsy and FNAC from 
lymph node were advised. Skin biopsy showed an infiltrate of 
atypical lymphoid cells abutting the epidermis having indented 
nuclei with the presence of characteristic Pautriers microabscess 
within the epidermis. The mid dermis also had a nodular 
perivascular infiltrate of similar cells (Fig. 4). The cells showed 
immunopositivity for CD3, CD4 and were immunonegative for 
CD8. FNAC smears from both cervical and axillary lymph nodes 
revealed infiltration by atypical cells, many with characteristic 
indented cerebriform nuclei. 
DISCUSSION
Cutaneous T cell lymphomas are a rare composite group including 
mycoses fungoides, primary cutaneous CD30 positive T-cell 
lymphoproliferative disorders, primary cutaneous peripheral T 
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cell lymphomas, rare subtypes, most common being mycoses 
fungoides [1]. When these cells appear in the blood, it amounts 
to Sezary syndrome and it can arise de novo too [6]. As stated 
previously, it is very rare and uncommon in young individuals, 
as in our case, which was only 23 years old. It is more common 
in males as was seen in our case too [1]. Sezary syndrome can 
involve any organ, most common being oropharynx, lungs 
and CNS [1]. Bone marrow involvement is variable and was 
uninvolved in our case [1]. In addition to the classical presenting 
features, there can be pruritus, alopecia, ectropion, palmoplantar 
hyperkeratosis and onychodystrophy [1] but none of these were 
seen in our case. 
Cutaneous T cell lymphoma is rare in HIV positive patients 
as compared to B cell Non-Hodgkin lymphomas. In a 3-year 
prospective study of 1161 HIV positive patients, Munoz MA et 
al found only two cases of mycosis fungoides [7]. Kerschmann 
et al in their study found only 8 cases of mycosis/sezary in HIV 
positive patients out of 25 cases with non-Hodgkin lymphoma [8]. 
Esteve et al could also found only one case of mycosis amongst 
8 cases of cutaneous lymphomas in retropositive patients [9]. The 
association of Sezary with HIV is rarer; on an extensive search, 
we could only find two reported cases of Sezary syndrome 
associated with HIV [4,10].
Etiopathogenesis of this syndrome remains unsolved. Many 
viruses like Human T cell Leukemia virus -1, Ebstein Barr virus, 
have been implicated as causative agents. Some authors have 
suggested the pathogenic pathway involved in epidermotropic 
nature of the disease [11]. According to them, there occurs 
increased production of IL-1 by the keratinocytes, which in turn 
leads to an elevated expression of intercellular adhesion molecule 
-1 on both endothelial cells as well as on keratinocytes. This 
leads to increased binding of the atypical helper T cells to these 
keratinocytes as well as endothelial cells [11].
Diagnosis of Sezary syndrome rests on identifying the 
pathognomic sezary cells in the peripheral blood. These cells have 
a highly indented nucleus and resemble cerebrum hence, called 
cerebriform. An absolute count of >1000/ mm3 of Sezary cells 
is required for diagnosis, in our case, it was 8160/microlitre [1]. 
Figure 2: (2a) Peripheral smear showing lymphocytosis, 200X, 
Giemsa stain, (2b) Peripheral smear showing characteristic sezary 
cells, 400x, Giemsa stain, Inset: Sezary cell showing cerebriform 
nucleus, 1000x, Giemsa stain
Figure 3a: Flow cytometry showing a bright lymphoid cluster with 
majority CD19 negative and CD 5 positive
Figure 3b: Flow cytometry showing lymphoid cluster with 
positivity for CD 3, CD4 and negativity for CD 7
Figure 1: (1a) Raised popular erythematous lesions on upper limbs 
and trunk, (1b) Scaling over the lesions
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Immunophenotypically, these are helper T cells which show loss 
of T cell antigens. Characteristically, these are negative for CD7 
and CD26 [1]. In our case too, these cells were immunopositive 
for CD3, CD4, CD5 and immunonegative for CD7. 
Skin biopsy is another very important modality with regard 
to diagnosis and further characterization. As noted in our case, it 
revealed the characteristic histopathological features of mycosis 
fungoides. However, in some cases of Sezary syndrome, the 
features can be very subtle and hence many sequential biopsies 
may be required to arrive at the diagnosis [12]. At times, the 
TCR gene rearrangement analysis may be needed to establish the 
diagnosis. 
Treatment of Sezary syndrome is palliative and is stage 
dependent. Skin-directed therapies, biological response modifiers, 
and chemotherapy are the mainstays of available options. 
Biological responses modifiers are under experimental trial are 
only used along with the topical therapies. Chemotherapy is used 
for advanced cases, the most common being CHOP regimen [12]. 
Our patient got discharged to take a referral from another center 
and hence, could not be followed up. Although mycoses fungoides 
has an indolent course, the prognosis of Sezary syndrome is worse 
with a median survival as low as three to four years [11].
CONCLUSION
Sezary syndrome is rare in HIV positive patients and in young 
males. As highlighted by our case, it should be kept as a differential 
diagnosis in retropositive young males who are presented with 
generalized lymphadenopathy and skin rash. A simple peripheral 
blood examination can give an early clue to the diagnosis which 
can be further confirmed by flow cytometry, skin and lymph node 
biopsy with immunohistochemistry. 
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Figure 4: Skin biopsy report (4a) epidermotropic as well as dermal 
infiltrate, 40x, H&E, (4b) epidermotropic infiltrate of atypical cells, 
100x, H&E, (4c) atypical cells in the dermis, 400x, H&E, 
(4d) pautriers microabscess in the epidermis, 400x, H&E
